AIDS2026: Is HIV remission the new cure?
By Heather Ellis This article was originally published in Positive Living. Set against Rio’s flamboyant backdrop of strong activism, AIDS2026
HIV Cure Research: A discrete choice experiment
Your thoughts can help shape how future HIV cure trials and cure treatments are designed – making them safer, more ethical, and more community-friendly.
Why macrophages matter for HIV cure
The HIV virus can infect and live in cells in tissues and hide there. One of these hiding places is in a type of immune cell called macrophages.
Boosting anti-HIV immunity with pomalidomide
In a recent study, researchers at the University of Melbourne used the immune-enhancing drug, pomalidomide, to boost immunity against HIV.
HIV and the gut: Why it matters for a cure
By Dr Sushama Telwatte and Dr Jillian Lau When people think of HIV, they often picture it in the blood.
HIV cure updates from IAS Kigali
The latest in HIV treatment and PrEP from IAS 2025 by Heather Ellis Heather Ellis is a journalist, the communications
Reversing latent HIV with mRNA and lipid nanoparticles: A promising new strategy
By Bridget Fisher and Dr Michael Moso Latent HIV that remains ‘silent’ in CD4 T cells is a major barrier
HIV cure research in the media
HIV cure research was recently showcased on the Well Well Well podcast on Joy FM, hosted by Thorne Harbour Health.
Time to HIV viral rebound and post-treatment controller in HIV cure studies with treatment interruptions
By Dr Jesper D Gunst, Dr Jesal Gohil, Dr Ole S Sogaard, Dr Sarah Fidler Researchers from Denmark and The
Would you interrupt treatment for HIV cure research?
Researchers want to know what you think about HIV cure studies being designed and performed in Australia. Your opinions are valued
Immune checkpoint blockade – a treatment for cancer with potential for HIV?
Dr Hannah King, postdoctoral research fellow, Doherty Institute What is immune checkpoint blockade? Immune checkpoints are proteins on the surface
Unpacking the HIV science at AIDS2024
With an HIV cure more elusive than ever, Heather Ellis finds that HIV scientists have turned their attention to innovative ‘nano-formulation’ strategies. By attending AIDS2024 from the comfort of home, she discovered how they plan to out-smart HIV in hiding and develop more effective treatments that will hopefully reduce the HIV reservoir and therefore low-level inflammation.